6190 — PhoenixBio Co Income Statement
0.000.00%
Last trade - 00:00Annual income statement for PhoenixBio Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,325 | 2,124 | 1,715 | 1,541 | 1,566 |
| Cost of Revenue | |||||
| Gross Profit | 728 | 1,556 | 1,195 | 1,118 | 1,201 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,757 | 1,616 | 1,705 | 1,961 | 1,483 |
| Operating Profit | -433 | 508 | 10 | -420 | 82.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -393 | 511 | 59.8 | -433 | 132 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -388 | 493 | 26.4 | -449 | 126 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -388 | 493 | 26.4 | -449 | 126 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -388 | 493 | 26.4 | -449 | 126 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -65.3 | 97.4 | 7.09 | -66.4 | 30.8 |
| Dividends per Share |